Bharat Parenterals Ltd. benchmarking: Perfomance to industry peers

Financial

	Bharat Parenterals	Ind-Swift Lab.	Anuh Pharma
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.31 %	2.9 %	0.0
Financials
5 yr Average ROE	7.88 %	14.53 %	15.87 %
5yr average Equity Multiplier	1.84	2.17	1.62
5yr Average Asset Turnover Ratio	0.73	0.66	1.35
5yr Avg Net Profit Margin	5.85 %	16.17 %	7.23 %
Price to Book	2.31	0.6	2.35
P/E	0.0	3.27	19.87
5yr Avg Cash Conversion Cycle	107.3 Days	15.71 Days	42.81 Days
Inventory Days	52.36 Days	103.91 Days	50.87 Days
Days Receivable	167.45 Days	105.66 Days	111.12 Days
Days Payable	103.87 Days	107.02 Days	117.6 Days
5yr Average Interest Coverage Ratio	14.58	21.19	48.66
5yr Avg ROCE	9.5 %	12.09 %	21.17 %
5yr Avg Operating Profit Margin	9.16 %	14.94 %	10.21 %
5 yr average Debt to Equity	0.36	0.91	0.02
5yr CAGR Net Profit	n/a	n/a	10.73 %
5yr Average Return on Assets	5.04 %	11.49 %	9.84 %
Shareholdings
Promoter Holding	67.19 %	39.5 %	71.82 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.65 %	-2.5 %	1.23 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bharat Parenterals	Ind-Swift Lab.	Anuh Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Bulk drug and Chemicals 0	Product Wise Break-Up Bulk drug and Chemicals 0 Pharmaceutical 0 Others 100	Product Wise Break-Up Bulk drug and Chemicals 100.0 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 76.17 India 23.83	Location Wise Break-Up Rest of the World 0 India 27.72 Others 72.28	Location Wise Break-Up Rest of the World 0 India 45.02 Others 54.98